NATIONAL MARROW DONOR PROGRAM

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$8.5M

Filings

149

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$930,000	3	1
2025	$1,140,000	4	1
2024	$920,000	4	1
2023	$990,000	5	1
2022	$130,000	2	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	$172,492	7	2
2014	$308,992	10	2
2013	$305,222	8	2
2012	—	8	2
2011	$229,064	8	2
2010	$437,287	12	3
2009	$328,799	14	3
2008	$495,075	14	3
2007	$400,000	6	3
2006	$320,000	6	3
2005	$460,000	5	3
2004	$500,000	3	2
2003	$200,000	2	2
2002	$80,000	2	2
2001	$100,000	4	2
2000	$40,000	3	2
1999	$20,000	3	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
NATIONAL MARROW DONOR PROGRAM	$8,506,931	64
SQUIRE PATTON BOGGS	—	38
LESTER HEALTH LAW PLLC	—	26
THE NICKLES GROUP, LLC	—	21

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	139
SENATE	139
Health Resources & Services Administration (HRSA)	53
Centers For Medicare and Medicaid Services (CMS)	33
Health & Human Services, Dept of (HHS)	30
Executive Office of the President (EOP)	24
Office of Management & Budget (OMB)	13
U.S. Customs & Border Protection	11
Transportation Security Administration (TSA)	10
White House Office	10
Federal Aviation Administration (FAA)	5
Consumer Financial Protection Bureau (CFPB)	2
Food & Drug Administration (FDA)	1
Homeland Security, Dept of (DHS)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	133
Health Issues	Health Issues	125
Medicare/Medicaid	Medicare/Medicaid	63
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	13
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	12
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	12
Transportation	Transportation	10
Trade (domestic/foreign)	Trade (domestic/foreign)	3
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	2
Defense	Defense	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.

Client expense: $310,000 · Firm income: —

Matched citations: H.R. 3521

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · third_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.

Client expense: $310,000 · Firm income: —

Matched citations: H.R. 5160

S. 4109119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

2026 · third_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.

Client expense: $310,000 · Firm income: —

Matched citations: S. 4109

S. 4440119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.

Client expense: $310,000 · Firm income: —

Matched citations: S. 4440

Show 21 more cited filings

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · second_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109.

Client expense: $300,000 · Firm income: —

Matched citations: H.R. 5160

S. 4109119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

2026 · second_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109.

Client expense: $300,000 · Firm income: —

Matched citations: S. 4109

H.R. 138119th Congress

Lowering Costs for Caregivers Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 138

H.R. 1509119th Congress

Accelerating Kids’ Access to Care Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 1509

H.R. 2036119th Congress

Credit for Caring Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 2036

H.R. 2491119th Congress

ABC Act

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 2491

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 5160

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: H.R. 5178

S. 1227119th Congress

ABC Act

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 1227

S. 1565119th Congress

Lowering Costs for Caregivers Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 1565

S. 4109119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2026

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 4109

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 721

S. 752119th Congress

Accelerating Kids’ Access to Care Act

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 752

S. 925119th Congress

Credit for Caring Act of 2025

2026 · first_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Client expense: $320,000 · Firm income: —

Matched citations: S. 925

H.R. 1509119th Congress

Accelerating Kids’ Access to Care Act of 2025

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: H.R. 1509

H.R. 2036119th Congress

Credit for Caring Act of 2025

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: H.R. 2036

H.R. 2491119th Congress

ABC Act

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: H.R. 2491

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: H.R. 5160

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: H.R. 5178

S. 1227119th Congress

ABC Act

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: S. 1227

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · fourth_quarter · Firm: NATIONAL MARROW DONOR PROGRAM

Open original LDA filing ↗

Cited source text and reported amounts

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721.

Client expense: $280,000 · Firm income: —

Matched citations: S. 721

Source: Senate LDA

NATIONAL MARROW DONOR PROGRAM — Lobbying Disclosure | Poliscope